MarketingMedicalPolicy,Access,Value, andEvidenceConsultingData,Technology,and Media
murmuration of birds
Previous
Next

thought leadership

Driving integrated access strategies through next-generation evidence at ISPOR Europe 2023, Copenhagen, November 12–15

10/16/2023

Meet senior experts from Avalere Health at ISPOR Europe 2023 at booth C3-065. It’s the perfect time to find out how our best-in-class, end‑to‑end policy, access, value, and evidence services are supporting leading life sciences companies, health plan providers, and investors.

Join the Avalere Health insight sessions at ISPOR Europe, booth C3-065

Join our complimentary* insights sessions at booth C3-065. Led by experts in policy, access, value, and evidence, it’s your opportunity to hear the latest thought-leadership, ask questions, and gain recommendations.

 

Joint clinical assessments (JCAs): navigating the complexities in 2025 and beyond
  • Monday, November 13, 9:45–10:15 AM
  • Tuesday, November 14, 9:45–10:15 AM

 

Early pipeline planning: tools and best practices for early decision-making
  • Monday, November 13, 11:15–11:45 AM
  • Tuesday, November 14, 11:15–11:45 AM

 

Harnessing the power of real-world evidence to elevate value
  • Monday, November 13, 2:45–3:15 PM
  • Tuesday, November 14, 2:45–3:15 PM

 

Reserve your spot today

Complimentary sessions are subject to availability. If you have been successful in securing a place at your chosen session, you will receive a confirmation email from us. Please bring this your confirmation email to the session.

Contact us

You may opt-out from our marketing emails at any time using the unsubscribe link in our emails. The data you submit will be processed as outlined in our privacy policy, cookie policy, and terms and conditions.

 

Unlock and optimize product value and patient access from early development through to loss of exclusivity and beyond with our suite of unique digital applications
  • hēRo3 Advanced HEOR modeling simplified
  • PRMA Healthcheck® Maximize the value of your asset portfolio at all stages of development
  • PRMA Navigator® Market access operational excellence to efficiently and effectively deliver high-quality multiple HTA and other payer submissions
  • PRMA Tracker® Track the evolving HTA and P&R landscape for key competitors or products of interest

 

On-demand e-learning with MALCOM: market access learning compendium

Helping your HEOR and market access teams to upskill and keep their finger on the pulse of evolving landscapes, MALCOM e-learning underpins the practical market access experience of new starters and/or existing members of cross-functional teams.

 

Avalere Health: your strategic thought partner for navigating the intersections between policy, health economics, and market access 

We can ensure your evidence generation efforts demonstrate high clinical value and applicability across borders. Our experts are available to discuss the following priorities at ISPOR Europe:  

  • Evidence utility across markets Policies such as the JCAs and the Inflation Reduction Act (IRA) are reshaping the value landscape globally. These changes highlight the importance of transferability, including aspects like cost-effectiveness and the limitations of available data, and the need for “integrated” evidence plans that promote cross-border transferability 
  • Value of quantitative and qualitative data Mixed-method research strategies are often best suited to address questions around health equity, SDOH, and the total disease impact. This includes not only the economic burden but also the indirect burden, encompassing indirect medical costs and the uncovered expenses shouldered by caregivers 
  • Patient centricity in HEOR Increasingly, stakeholders are demanding non-traditional evidence to answer complex questions about patient outcomes in real-world treatment settings. It is critical to explore new ways to measure healthcare quality and develop shared decision-making tools to ensure that patients remain at the center of healthcare decisions 
  • Early pipeline strategy Early decision-making is crucial given the substantial investment to conduct clinical trials and bring products to market. Our experts are adept at offering insights into investment decisions, the assessment of product lifecycles, clinical development programs, and the strategic planning of early pipeline development. 

 

Meet the experts from Avalere Health for drinks! 
Monday, November 13, 6:00 PM at booth C3-065

 

Making science accessible to every patient

In an interview ahead of ISPOR Europe 2023, senior colleagues keenly anticipated the value that our connected teams will offer delegates at the upcoming exhibition:

 

ISPOR Europe 2023 is a great place to meet our policy, access, value, and evidence experts. With deep knowledge of quickly evolving policy and market access landscapes, and the implications for portfolio and commercialization strategies, they will help you develop robust strategies and agile solutions in a changing healthcare environment.

Jon Koch

CEO, Avalere Health

avatar for Jon Koch - CEO, Avalere Health

 

Our world is changing, expectations are changing. Utilizing the same approach to market access in the face of evolving challenges and definitions of value is no longer sustainable. At Avalere Health, we have built first-class capabilities across HEOR, market access, value engagement, and policy to deliver joined-up and agile partnerships. We meet your needs to help make science accessible to every patient.

Tim Wright

President, Global Policy, Access, Value, and Evidence

avatar for Tim Wright - President, Global Policy, Access, Value, and Evidence

 

We understand policy, we understand market access, we understand evidence and value engagement – not only in the US, but also across Europe and the Asia-Pacific region. It’s not necessarily difficult to find expertise in any one of those areas, but it’s hard to find a company that delivers it all. I’m excited to introduce you to our integrated global offering at ISPOR Europe 2023.

Sarah Alwardt

President, Avalere (Part of Avalere Health)

avatar for Sarah Alwardt - President, Avalere (Part of Avalere Health)

How we use cookies

Cookies are files saved on your phone, tablet or computer when you visit a website.

We use cookies to store information about how you use the Fishawack Health website, such as the pages you visit.

For more information, check the cookie statement

32E8261E-A569-4B66-ACC6-3CB772DDEDEE

Cookie settings

We use 4 types of cookies. You can choose which cookies you're happy for us to use.

Cookies that measure website use.

We use Google Analytics to measure how you use the website so we can improve it based on user needs. We do not allow Google to use or share the data about how you use this site.

  • how you got to the site
  • the pages you visit on fishawack.com, and how long you spend on each page
  • what you click on while you're visiting the site

Cookies that help with our communications and marketing

These cookies may be set by third party websites and do things like measure how you view Vimeo videos that are on Fishawack.com.

Cookies that remember your settings

These cookies do things like remember your preferences and the choices you make, to personalize your experience of using the site.

Strictly necessary cookies

These essential cookies do things like remember your progress through a form (eg. Registering for new content alerts).

These cookies always need to be on.